Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Evaluate which tax lot harvesting approach—ETFs or mutual funds—yields lower taxes in retirement and aligns with your plan.
25,078 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
MicroStrategy offloads 32 BTC to cover dividend payouts on its perpetual preferred shares, signaling a shift from a p...
Celebrities walk a fine line between humor and harm. When kevin hart says oprah is off-limits, it reveals how powerfu...
Cathie Wood goes bargain moves reflect Ark Invest's hunt for disruptive tech at a discount. Explore three stocks she ...
A high profile event can reveal how big budgets behave. This article translates that spectacle into actionable person...
Dave Ramsey reveals a practical, three-bucket framework to turn generosity into a deliberate, scalable habit as donor...
A real-world tech-support scam drained a couple’s life savings before authorities stopped the final transfer. This in...
Hillary Clinton testifies in New York as part of a House probe into Jeffrey Epstein, with Bill Clinton expected to fo...
TSA workers in Atlanta push for a resolution to the DHS shutdown after more than a month without pay, highlighting pe...
Nebius stock all-time high sparked a flurry of questions. This guide breaks down the drivers, the risks, and a practi...
Markets ride to new highs while anxiety hits home for many investors paralyzed right now. This report explains why an...